Anticoagulation in Peripheral Artery Disease: Are We There Yet?
Thromboembolism in patients with peripheral artery disease (PAD) represents a common cause of morbidity and mortality. In this article, the authors analyse the use of anticoagulants for patients with PAD. Anticoagulants have been used to reduce the risk of venous thromboembolism, but have recently b...
Main Authors: | Alessandro Cannavale, Mariangela Santoni, Giuseppe Cannavale, Fabrizio Fanelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-09-01
|
Series: | Vascular and Endovascular Review |
Online Access: | https://www.verjournal.com/articles/anticoagulation-in-peripheral-artery-disease |
Similar Items
-
Chromogenic Technologies for Energy Saving
by: Alessandro Cannavale
Published: (2020-11-01) -
Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment
by: Emanuele Boatta, et al.
Published: (2013-04-01) -
Peripheral control of psychiatric disorders: Focus on OCD. Are we there yet?
by: Fulvio D'Acquisto, et al.
Published: (2023-05-01) -
We are not there yet
by: Margaret I. Fitch
Published: (2022-07-01) -
Are we there yet?
by: Lajos Balogh
Published: (2023-03-01)